These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37783269)

  • 1. Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    Malik GMA; Samiullah FNU; Khenhrani RR
    J Cardiol; 2024 Feb; 83(2):138. PubMed ID: 37783269
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    Klarskov VR; Ladefoged BT; Pedersen ALD; Hartig-Andreasen C; Clemmensen TS; Poulsen SH
    J Cardiol; 2023 Aug; 82(2):122-127. PubMed ID: 37141937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
    Galant NJ; Westermark P; Higaki JN; Chakrabartty A
    Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
    Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
    Gertz MA; Benson MD; Dyck PJ; Grogan M; Coelho T; Cruz M; Berk JL; Plante-Bordeneuve V; Schmidt HHJ; Merlini G
    J Am Coll Cardiol; 2015 Dec; 66(21):2451-2466. PubMed ID: 26610878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy.
    Martín-Álvarez E; Larrañaga-Moreira JM; Barge-Caballero G; Souto-Caínzos B; Crepo-Leiro MG; Barriales-Villa R
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):347-349. PubMed ID: 38043734
    [No Abstract]   [Full Text] [Related]  

  • 8. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
    Varedi D; Kovacsovics T; Downs Kelly E; Abraham J; Cowley J; Barrell K; Revelo MP; Stehlik J; Drakos S; Marrouche N; Wilson B; Swanson EA; Fang J; Nativi-Nicolau J
    Circ Heart Fail; 2018 Jul; 11(7):e004812. PubMed ID: 29921704
    [No Abstract]   [Full Text] [Related]  

  • 9. Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity.
    Lee YZJ; Fajardo J; Brown E; D'Adamo CR; Judge DP
    J Cardiovasc Transl Res; 2022 Aug; 15(4):689-691. PubMed ID: 35083733
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute cardiac failure secondary to senile systemic amyloidosis.
    Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
    Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
    Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
    Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
    [No Abstract]   [Full Text] [Related]  

  • 12. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
    Papathanasiou M; Carpinteiro A; Kersting D; Jakstaite AM; Hagenacker T; Schlosser TW; Rischpler C; Rassaf T; Luedike P
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1581. PubMed ID: 33345470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons.
    Sueyoshi T; Ueda M; Jono H; Irie H; Sei A; Ide J; Ando Y; Mizuta H
    Hum Pathol; 2011 Sep; 42(9):1259-64. PubMed ID: 21334722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.
    Shintani Y; Okada A; Morita Y; Hamatani Y; Amano M; Takahama H; Amaki M; Hasegawa T; Ohta-Ogo K; Kanzaki H; Ishibashi-Ueda H; Yasuda S; Shimazaki C; Yoshinaga T; Yazaki M; Sekijima Y; Izumi C
    ESC Heart Fail; 2019 Feb; 6(1):232-236. PubMed ID: 30478886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative management for liver transplant in a patient with familial amyloid polyneuropathy with heart involvement.
    López-Herrera Rodríguez D; Guerrero Domínguez R; Mellado Miras P; Gómez Sosa L
    Rev Esp Anestesiol Reanim; 2015 Jan; 62(1):46-8. PubMed ID: 24742789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stumbling across transthyretin amyloid cardiomyopathy during diagnostic work-up for stomach cancer.
    Lee HK; Choi YS; Han EJ; Sung YE; Youn JC
    Korean J Intern Med; 2023 Mar; 38(2):273-274. PubMed ID: 36321342
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
    JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.